Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization

doi:10.3748/wjg.v24.i15.1641

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 15

This Article

(327)

(330)

(0)

(11)

(3)

(8478)

(10)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastroenterol. Apr 21, 2018; 24(15): 1641-1649
Published online Apr 21, 2018. doi: 10.3748/wjg.v24.i15.1641

Table 2 Characteristics of patients in the total cohort

Parameter¹	Value
Age (yr)	64.24 ± 10.35
Sex (M) (%)	124 (74.25)
Cirrhosis (yes) (%)	134 (80.24)
AFP (ng/dL)	1769.49 ± 7297.65
AFP (median, range)	53.80 (1-66000)
AFP > 100 (%)	54 (40.60)
Number nodules	1.95 ± 1.39
MTD (cm)	4.45 ± 2.64
PVT (yes) (%)	24 (14.37)
Aggressiveness index score (%)
Score > 4	75 (63.56)
Total bilirubin (mg/dL)	1.23 ± 0.80
ALKP (IU/mL)	133.29 ± 74.74
GGTP (IU/mL)	152.26 ± 152.80
AST (IU/L)	104.68 ± 110.73
ALT (IU/L)	77.85 ± 88.25
Albumin (g/dL)	3.63 ± 1.93
Platelet count (× 10⁹/L)	113.78 ± 82.70
WBC (× 10⁹/L)	5.46 ± 2.59
Lymphocyte (× 10⁹/L)	1.41 ± 0.98
Survival time (median, range)	38 (3-175)

¹All values: mean ± SD for continuous variables; Aggressiveness Index (sum of scores): MTD (in tertiles): MTD < 4.5; 4.5 ≤ MTD ≤ 9.6; MTD > 9.6; scores 1, 2, 3 respectively; AFP (cut-off): AFP < 100; 100 ≤ AFP ≤1000; AFP > 1000; scores 1, 2, 3 respectively; PVT (no/yes): PVT (no); PVT (yes); scores 1, 3 respectively; Nodules (number): Nodules ≤ 3; Nodules > 3; scores 1, 3 respectively. AFP: Alpha-fetoprotein; MTD: Maximum tumor diameter; PVT: Portal vein thrombosis; ALKP: Alkaline phosphatase; GGTP: Gamma glutamyl transpeptidae; AST: Aspartate aminotransaminase; ALT: Alanina amminotransferasi; Hb: Haemoglobin; WBC: White blood cell.

Full Size Table

Citation: Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649
URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1641.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i15.1641

Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649 [PMID: 29686471 DOI: 10.3748/wjg.v24.i15.1641]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.